By promoting ROS generation, inhibiting the PI3K/AKT signaling pathway, activating AMPK, and modulating MAPK, these compounds not only enhance the expression of autophagy-related proteins but also suppress cell proliferation and migration, demonstrating selective cytotoxic potential against cancer cells and highlighting their promise in cancer treatment (Figure 7). The gene discussed is AKT1; the disease is cancer.